{"schema_version":"secwatch.filing_event.v1","accession":"0001932393-24-000051","form_type":"8-K","ticker":"GEHC","cik":"0001932393","company_name":"GE HealthCare Technologies Inc.","filed_at":"2024-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.373526+00:00","generated_at":"2026-05-30T08:36:06.344004+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"GE HealthCare realigns IGT to AVS segment; recasts 2022-2024 segment revenue and EBIT","bullets":["Effective July 1, 2024, Image Guided Therapies moved from Imaging to Ultrasound, renamed Advanced Visualization Solutions (AVS).","Recast Q2 2024 Imaging revenue $2,171M; AVS revenue $1,249M (Procedural Guidance $668M, Specialized Ultrasound $581M).","Recast Q2 2024 Segment EBIT: Imaging $208M, AVS $255M, PCS $78M, PDx $200M.","Total revenue and EBIT unchanged; company now reports four segments: Imaging, AVS, PCS, PDx."],"urls":{"canonical":"https://secwatch.observer/filing/0001932393-24-000051","json":"https://secwatch.observer/filing/0001932393-24-000051.json","markdown":"https://secwatch.observer/filing/0001932393-24-000051.md","text":"https://secwatch.observer/filing/0001932393-24-000051.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1932393/000193239324000051/0001932393-24-000051-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1932393/000193239324000051/gehc-20241030.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T08:36:06.344004+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}